Targeting of Drugs 4: Advances in System Constructs

Drug Targeting with Glycoproteins and other Peptide Carriers: An Overview, D.K.F. Meijer. Sugar Specific Delivery of Drugs, Oligonucleotides, and Genes, M. Monsigny, et al. The Use of MSH Derivatives for Targeting to Melanomas, D.R. Bard, et al. The Immunogenicity of Recombinant Proteins and of 'Magic Bullets' Represents the Main Obstacle for the Effective in vivo Targeting of Biological Response Modifiers (BRMs), A.H. Sehon. Targeting of Drugs to Tumors: The Use of the Plasminogen Activator Inhibitor as a Ligand, J. Jankun. Advances in Diagnosis and Treatment of Neoplasia Using Radioactive Monoclonal Antibodies, A. Maraveyas, A.A. Epenetos. Targeting Transcription Factors to Inhibit Selectively Gene Expression in Particular Cell Types, A.C. Allison, E.M. Eugui. Design, Biological Properties and Delivery of Antisense Oligonucleotides, J.S. Cohen. Liposomes in vivo: Control of Behaviour, G. Gregoriadis. Passive Targeting of Anthracyclines Entrapped in Longcirculating (Stealth) Liposomes in the Treatment of Cancer, T.M. Allen. Liposomal Drug Delivery: Possibilities for Manipulation, G. Storm, et al. 6 additional articles. Index.... Mehr